Topic: healthcare biotech investments

Catalio Capital Raises $400M+ for Fund IV

Catalio Capital Management raised over $400 million for Fund IV, emphasizing its focus on healthcare and biotech innovation despite market challenges. The firm has invested in 100+ startups, including recent bets like PinkDx and Superluminal Medicines, building on earlier funds like its $381 mill...